Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-24-2-5p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 290, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
SPRY2 hsa-miR-24-2-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xiaoni Li et al. 2013 RP Mammary Gland MCF7 MCF7 N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay POSITIVE DIRECT TarBase 8.0
WEE1 hsa-miR-24-2-5p low: 0 high: 9 2 2 2 0.687
High-throughput experiments (9 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr11:9589073-9589095 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:9589073-9589095 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:9589073-9589095 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr11:9589073-9589095 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr11:9589073-9589095 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr11:9589073-9589095 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:9589073-9589095 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:9589073-9589095 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:9589073-9589095 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TMEM194A hsa-miR-24-2-5p low: 0 high: 6 3 3 3 -
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr12:57058156-57058178 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr12:57058156-57058178 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:57058156-57058178 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr12:57058156-57058178 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr12:57058156-57058178 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HMSC N/A N/A
Location Method Result Regulation Validation Type Source
chr12:57058156-57058178 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RBL1 hsa-miR-24-2-5p low: 0 high: 3 1 3 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr20:36997706-36997730 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:36997706-36997730 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:36997706-36997730 PAR-CLIP POSITIVE DIRECT TarBase 7.0
RMND5A hsa-miR-24-2-5p low: 0 high: 3 3 3 3 0.671
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr2:86777152-86777177 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr2:86777152-86777177 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr2:86765928-86765949 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PCBP1 hsa-miR-24-2-5p low: 0 high: 3 3 3 3 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr2:70088696-70088720 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr2:70088696-70088720 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr2:70088696-70088720 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FNIP1 hsa-miR-24-2-5p low: 0 high: 3 2 3 3 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland MDAMB231 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:131651914-131651940 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr5:131651914-131651940 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HMSC N/A N/A
Location Method Result Regulation Validation Type Source
chr5:131651914-131651940 HITS-CLIP POSITIVE DIRECT TarBase 7.0
C12orf57 hsa-miR-24-2-5p low: 0 high: 3 2 2 2 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:6943824-6943851 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr12:6943824-6943851 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:6943824-6943851 HITS-CLIP POSITIVE DIRECT TarBase 7.0
AHNAK hsa-miR-24-2-5p low: 0 high: 3 2 2 2 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr11:62527144-62527164 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr11:62527144-62527164 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62520733-62520761 HITS-CLIP POSITIVE DIRECT TarBase 7.0
VCL hsa-miR-24-2-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr10:74118397-74118423 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HMSC N/A N/A
Location Method Result Regulation Validation Type Source
chr10:74118397-74118423 HITS-CLIP POSITIVE DIRECT TarBase 7.0
IPO5 hsa-miR-24-2-5p low: 0 high: 2 1 2 2 0.518
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr13:98019654-98019674 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HMSC N/A N/A
Location Method Result Regulation Validation Type Source
chr13:98019654-98019674 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PABPC1 hsa-miR-24-2-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr8:100718176-100718189 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr8:100718176-100718189 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GNB1 hsa-miR-24-2-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr1:1785492-1785513 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr1:1785492-1785513 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PITPNM2 hsa-miR-24-2-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr12:122984189-122984210 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr12:122987580-122987604 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CMTM6 hsa-miR-24-2-5p low: 0 high: 2 2 2 2 0.554
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr3:32483788-32483815 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr3:32483788-32483815 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RPL34 hsa-miR-24-2-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr4:108621965-108621990 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr4:108621965-108621990 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PVRL1 hsa-miR-24-2-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr11:119662895-119662909 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr11:119662895-119662909 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EFEMP1 hsa-miR-24-2-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr2:55866917-55866936 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr2:55866917-55866936 HITS-CLIP POSITIVE DIRECT TarBase 7.0
BIRC6 hsa-miR-24-2-5p low: 0 high: 2 1 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr2:32611530-32611550 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:32611530-32611550 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SFPQ hsa-miR-24-2-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:35192683-35192701 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr1:35192683-35192701 HITS-CLIP POSITIVE DIRECT TarBase 7.0